Treatment of persistent postpneumonectomy empyema by vacuum-assisted management: an analysis of nine patients

Ali Celik1, Erdal Yekeler, Ertan Aydın

  • 1Department of Thoracic Surgery, Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Keçiören, Ankara, Turkey.

Abstract

Insights

Vacuum-assisted management (VAM) effectively treats postpneumonectomy empyema (PPE), offering a safe and successful alternative to conventional methods. This approach aids in continuous drainage and pouch obliteration, improving patient outcomes.

Area of Science:

  • Thoracic Surgery
  • Surgical Innovation
  • Infectious Disease Management

Background:

  • Postpneumonectomy empyema (PPE) presents significant challenges including prolonged hospitalization, patient discomfort, and high mortality rates with conventional treatments.
  • Vacuum-assisted management (VAM) emerges as a potential solution to mitigate these adverse outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of intrathoracic vacuum-assisted management (VAM) for treating postpneumonectomy empyema (PPE).
  • To assess VAM's role in continuous drainage and promoting pouch obliteration through enhanced tissue granulation.

Main Methods:

  • VAM was applied to nine patients diagnosed with PPE between July 2010 and September 2011.
  • The procedure involved continuous drainage of the empyema cavity and facilitation of granulation for pouch obliteration.

Main Results:

  • Treatment success was achieved in 88.9% (8 out of 9) of patients.
  • In patients without fistula (n=7), VAM led to empyema resolution and pouch obliteration.
  • In patients with fistula (n=2), VAM was initiated after fistula closure, also demonstrating success.
  • The mean hospital stay was 36.5 days, with a mean follow-up of 10.9 months in successfully treated cases.

Conclusions:

  • Intrathoracic vacuum-assisted management (VAM) is an effective and safe therapeutic option for postpneumonectomy empyema (PPE).
  • VAM facilitates continuous drainage and promotes healing, leading to successful treatment outcomes in a majority of patients.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: